$11M sweet spot round size
Most of their 27 investments are in rounds between $6.6M and $16M
1983
PhaseBio Pharmaceuticals, Inc. raised $34M on September 5, 2018
Investors: Syno Capital, Mountain Group Partners and Fletcher Spaght, Inc.
HistoSonics, Inc. raised $8.3M on March 13, 2017
Investors: Grand Angels, TGap Ventures, EARLY STAGE PARTNERS L.P., Wolverine Venture Fund, Venture Investors and Fletcher Spaght, Inc.
Swift Biosciences, Inc raised $3M on April 15, 2016
Investors: Michigan Accelerator Fund I, Draper Associates and Fletcher Spaght, Inc.
PhaseBio Pharmaceuticals, Inc. raised $40M on March 12, 2015
Investors: Fletcher Spaght, Inc.
Metabolon, Inc. raised $15M on January 6, 2014
Investors: Fulcrum Equity Partners, Sumitomo Corporation, Camden Partners and Fletcher Spaght, Inc.
Swift Biosciences, Inc raised $7M on October 17, 2013
Investors: Renaissance Venture Capital Fund and Fletcher Spaght, Inc.
SURGIQUEST raised $7.5M on December 5, 2012
Investors: Presidio Partners, Aphelion Capital, California Technology Ventures, LLC, River Cities Capital and Fletcher Spaght, Inc.
Juventas Therapeutics, Inc. raised $22M on July 16, 2012
Investors: EARLY STAGE PARTNERS L.P., -, Takeda UK Limited, Triathlon Medical Ventures, Venture Investors and Fletcher Spaght, Inc.
PhaseBio Pharmaceuticals, Inc. raised $23M on June 5, 2012
Investors: Astellas Venture Capital L.L.C. and Fletcher Spaght, Inc.
Cayenne Medical raised $10M on February 14, 2012
Investors: MB Venture Partners, LLC, Capital Growth Investments Inc, Split Rock Partners and Fletcher Spaght, Inc.